Clinical Trials List
2021-07-01 - 2027-06-30
Phase III
Recruiting7
ICD-10C33
Malignant neoplasm of trachea
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.0
Malignant neoplasm of trachea
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 蕭慈慧 無
- 趙恒勝 無
- Chao-Hua Chiu 無
- Heng-Sheng Chao 未分科
- Hsu-ching Huang 無
- Chi-Lu Chiang 無
- Chia-I Shen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林宗哲 Division of Hematology & Oncology
- Chong-Jen Yu Division of General Internal Medicine
- 廖唯昱 Division of General Internal Medicine
- 吳尚俊 Division of General Internal Medicine
- Jih-Hsiang Lee Division of Hematology & Oncology
- JIN-YUAN SHIH Division of General Internal Medicine
- 許嘉林 Division of General Internal Medicine
- YEN-TING LIN Division of General Internal Medicine
- James Chih-Hsin Yang Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- 陳冠宇 Division of General Internal Medicine
- 蔡子修 Division of General Internal Medicine
- Chia-Chi Lin Division of Hematology & Oncology
- WEI-LI MA Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- 楊景堯 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wen-Pin Su Division of Hematology & Oncology
- Chun-Hui Lee Division of Hematology & Oncology
- Yu-Min Yeh Division of Hematology & Oncology
- Po-Lan Su Division of General Internal Medicine
- Shang-Yin Wu Division of Hematology & Oncology
- Wu-Chou Su Division of Hematology & Oncology
- Jui-Hung Tsai Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chih-Hung Chen Division of Hematology & Oncology
- 黃宗楨 Division of Hematology & Oncology
- 邱子萱 Division of Hematology & Oncology
- Chien-Ying Liu Division of Hematology & Oncology
- 黃繼賢 Division of Infectious Disease
- 李忠恕 Division of Hematology & Oncology
- Jia-Shiuan Ju Division of Hematology & Oncology
- 枋岳甫 Division of Hematology & Oncology
- 邱立忠 Division of Hematology & Oncology
- 柯皓文 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林慶雄 Division of Thoracic Medicine
- 紀炳銓 Division of Thoracic Medicine
- 黃國揚 Division of Thoracic Medicine
- 陳正雄 Division of Thoracic Medicine
- 張竣期 Division of Thoracic Medicine
- 詹博強 Division of Thoracic Medicine
- 葉金水 Division of Thoracic Medicine
- 蔡偉宏 Division of Thoracic Medicine
- 林明泰 Division of Thoracic Medicine
- 施穎銘 Division of Thoracic Medicine
- 林俊維 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Inn-Wen Chong Division of Thoracic Medicine
- 郭家佑 Division of Thoracic Medicine
- Chih-Jen Yang Division of Thoracic Medicine
- KUAN-LI WU Division of Thoracic Medicine
- 李玫萱 Division of Thoracic Medicine
- 莊政皓 Division of Thoracic Medicine
- Ying-Ming Tsai Tsai Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
37 participants
-
Global
512 participants
